Mechanisms of genomic instability in breast cancer

PHG Duijf, D Nanayakkara, K Nones, S Srihari… - Trends in molecular …, 2019 - cell.com
Breast cancer is the most common cancer among women globally. Genomic instability (GI)
refers to the increased tendency to accrue genomic alterations. It drives heterogeneity and is …

Advances and perspectives of PARP inhibitors

M Yi, B Dong, S Qin, Q Chu, K Wu, S Luo - Experimental hematology & …, 2019 - Springer
DNA damage repair deficiency leads to the increased risk of genome instability and
oncogenic transformation. In the meanwhile, this deficiency could be exploited for cancer …

A novel hypoxic long noncoding RNA KB-1980E6. 3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability

P Zhu, F He, Y Hou, G Tu, Q Li, T Jin, H Zeng, Y Qin… - Oncogene, 2021 - nature.com
The hostile hypoxic microenvironment takes primary responsibility for the rapid expansion of
breast cancer tumors. However, the underlying mechanism is not fully understood. Here …

Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression

G Liang, Y Ling, M Mehrpour, PE Saw, Z Liu, W Tan… - Molecular cancer, 2020 - Springer
Abstract Background Although both circular RNAs (circRNAs) and autophagy are associated
with the function of breast cancer (BC), whether circRNAs regulate BC progression via …

Resveratrol in cancer therapy: from stimulation of genomic stability to adjuvant cancer therapy: a comprehensive review

P Amini, R Moazamiyanfar, MS Dakkali… - Current topics in …, 2023 - ingentaconnect.com
Cancer therapy through anticancer drugs and radiotherapy is associated with several side
effects as well as tumor resistance to therapy. The genotoxic effects of chemotherapy and …

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer

ZY Yeow, BG Lambrus, R Marlow, KH Zhan, MA Durin… - Nature, 2020 - nature.com
Genomic instability is a hallmark of cancer, and has a central role in the initiation and
development of breast cancer,. The success of poly-ADP ribose polymerase inhibitors in the …

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms

ZS Lima, M Ghadamzadeh, FT Arashloo… - Journal of hematology & …, 2019 - Springer
Breast cancer is the most common malignancy in women all over the world. Genetic
background of women contributes to her risk of having breast cancer. Certain inherited DNA …

[HTML][HTML] Saikosaponin D loaded macrophage membrane-biomimetic nanoparticles target angiogenic signaling for breast cancer therapy

K Sun, W Yu, B Ji, C Chen, H Yang, Y Du, M Song… - Applied Materials …, 2020 - Elsevier
Breast cancer remains the most frequently diagnosed malignancy among women
worldwide. Although effective, numerous treatment strategies have been developed, which …

MRPL13 promotes tumor cell proliferation, migration and EMT process in breast cancer through the PI3K-AKT-mTOR pathway

M Cai, H Li, R Chen, X Zhou - Cancer management and research, 2021 - Taylor & Francis
Purpose Breast cancer (BC), with varying histopathology, biology and response to systemic
treatment, is the second leading cause of cancer-related mortality. Previous studies have …

Extracellular vesicles in breast cancer: from biology and function to clinical diagnosis and therapeutic management

S Loric, JA Denis, C Desbene, M Sabbah… - International journal of …, 2023 - mdpi.com
Breast cancer (BC) is the first worldwide most frequent cancer in both sexes and the most
commonly diagnosed in females. Although BC mortality has been thoroughly declining over …